Pharma Archives - Page 3 of 5

Linda Krebs, & Allison Krebs-Bensch, of BeBe & Bella, LLC talk about V-Bella Homeopathic Boric Acid and Probiotic blend vaginal suppositories.

February 1, 2021 MarketsandMarkets Conferences

Linda and Allison have had a lifelong commitment to wellbeing and overall health. Living in the sunny South, they understand that proper skincare is an essential aspect of everyday life. In 2013 they became business partners creating the groundbreaking probiotic based skin care company – BeBe & Bella, LLC. Allison Krebs-Bensch, CEO of US Pharmaceutical Corporation, CEO and Co-Founder of BeBe & Bella, LLC followed her father in his original profession as a scientific innovator. As a trailblazer, Allison is always pushing to formulate products around new scientific discoveries. It…

Discussing ‘Reducing Errors at Point-Of-Care’ with Uchenna Okeahiala of Airedale and Bradford Hospitals Integrated Pathology Solutions, UK .

January 19, 2021 MarketsandMarkets Conferences

Graduated from University of Nigeria with a bachelor’s degree in Biomedical Sciences in 1989, Uchenna started her career as a Biomedical Scientist in Nigeria She relocated to the United Kingdom in 1991 where she obtained her Master’s degree in Biomedical Sciences from University of Cardiff with a Distinction in 1996 and went on to score a certificate in management from the Open University (1999). Later in 2006, she obtained a certificate in Extended Practice in Quality Management with Institute of Biomedical Sciences (IBMS). Since then has worked in various NHS…

Jyoti Chandok from Concordia University, Canada speaks about ‘Factors leading to the increase in demand POCT tech and challenges in upholding Quality Standards.’

January 14, 2021 MarketsandMarkets Conferences

Jyoti Chandok is a seasoned professional who has been working in the healthcare sector for over 19 years. She has fulfilled several roles specializing in patient care including phlebotomy, blood analysis for hematology, immunology, genetics, and specialized method development for HIV drug-level testing using mass spectrometry. Currently, Jyoti is an Assistant Chief Medical Technologist of Point-of-Care at the McGill University Health Center (MUHC) in Montreal, Quebec, Canada. She holds a B.Sc. in Cell and Molecular Biology from Concordia University and is an active member of both the Ordre professionnel des…

Julie Schwedock from Takeda Pharmaceuticals speaks about LBPs: What to consider when choosing CDMOs.

January 11, 2021 MarketsandMarkets Conferences

Julie Schwedock, PhD is Associate Director of the Microbial Development Team at Takeda Pharmaceuticals. She leads a cross-functional Pharmaceutical Sciences team for Live Bacterial Products (LBPs) focused on treating dysbiosis of the gut microbiome. She also heads a functional line group that works on process development for microbial expression systems as well as LPBs. Prior to that she was Associate Director of Analytical Development and QC at Vedanta Biosciences, also working with LBPs, where she developed analytics in an uncertain regulatory landscape for a product now in Ph2 clinical trials. …

Discussing combination strategies, pre-clinical and translational immune-oncology developments at the 4th Annual MarketsandMarkets Next Gen Immuno-Oncology Virtual Congress

September 7, 2020September 7, 2020 MarketsandMarkets Conferences

September 7th – The 4th Annual MarketsandMarkets Next Gen Immuno-Oncology Virtual Congress to be held on 29th – 30th October 2020 (British Standard Time) would address the challenges and future directions in IO research. The congress aims to bring academicians, researchers and scientists from research institutes pharmaceutical, bio-pharmaceutical and biotechnology companies to discuss the latest updates in development of ADC’s, Bispecific Antibodies, Cellular Therapy and Immune Checkpoint Inhibitors. 4th Annual MarketsandMarkets Next Gen Immuno-Oncology Virtual Congress will gather 20+ sponsors, 30+ leading industry speakers and 200+ professional. The 2-day event…

Speaker Interview with Sebastien Tabruyn for the 4th Annual MarketsandMarkets Next Gen Immuno-Oncology Congress

February 5, 2020 MarketsandMarkets Conferences

Sebastien Tabruyn holds a PhD in Molecular Biology from the University of Liege (Belgium). After 10 years of experience as Project leader in renowned international academic research institutes including UCSF (California, USA), the Centre for Cancer Biology (Adelaide, Australia) and the University of Maastricht (Netherlands), he joined TransCure bioServices in 2013 as Head of Molecular Biology and Oncology. Sebastien Tabruyn published 30 peer-reviewed publications in the field of Oncology, Angiogenesis, Inflammation and Immunity In a recent interview with MarketsandMarkets, Mr. Sebastien Tabruyn shared his thoughts on the current challenges that…

Call for Abstracts Announced for MarketsandMarkets Gen-Next Probiotics and Microbiome Congress

January 17, 2020 MarketsandMarkets Conferences

January 10, 2020 – Witness the major breakthroughs of microbiome, probiotics and prebiotics research along with their applications pertaining to challenges like medicinal data interpretation, investment and regulatory hurdles faced by the practitioners at the MarketsandMarkets Gen-Next Probiotics and Microbiome Congress taking place on February 6-7, 2020 at Sheraton San Diego Hotel & Marina. We are delighted to announce the submission of abstracts from January 10. The call for abstracts presents an opportunity for academic and industry experts to be a part of the two-day congress and showcase their expertise…

Speaker Interview with Fabio D’Agostino for 4th Annual MarketsandMarkets Bioprocessing of Advanced Cellular Therapies & Regenerative Medicine Congress

January 7, 2020 MarketsandMarkets Conferences

London, January 07 – MarketsandMarkets interviewed Fabio D’Agostino,Venture Partner, Claris Ventures regarding 4th Annual MarketsandMarkets Bioprocessing of Advanced Cellular Therapies & Regenerative Medicine Congress taking place on 10-11 March 2020 in London – UK. Q. What is the most trending areas of cellular therapies currently? A. CART and NK cell Q. What are the recent developments and technological advancements? A. CART for solid tumors and NK CAR Q. What are the key take away points from your presentation? A. They are basically summarized in my bullet points. I will…

Speaker Interview with Karin Jennbacken for 4th Annual MarketsandMarkets Bioprocessing of Advanced Cellular Therapies & Regenerative Medicine Congress

December 13, 2019December 16, 2019 MarketsandMarkets Conferences

London, December 13 – MarketsandMarkets interviewed Karin Jennbacken, Team Leader, Heart Failure in vitro team, AstraZeneca regarding 4th Annual MarketsandMarkets Bioprocessing of Advanced Cellular Therapies & Regenerative Medicine Congress taking place on 10-11 March 2020 in London – UK. Dr Jennbacken’s team is responsible for target discovery and early development of therapeutics for treatment of patients with cardiovascular disease. Q. What is the most trending areas of cellular therapies currently? A. Cardiac therapies using pluripotent stem cells is where most of the researches are going on. Q. What are the…

Speaker Interview with Petter Björquist for 4th Annual MarketsandMarkets Bioprocessing of Advanced Cellular Therapies & Regenerative Medicine Congress

December 13, 2019December 13, 2019 MarketsandMarkets Conferences

London, December 13 – MarketsandMarkets interviewed Petter Björquist, CEO, Verigraft regarding 4th Annual MarketsandMarkets Bioprocessing of Advanced Cellular Therapies & Regenerative Medicine Congress taking place on 10-11 March 2020 in London – UK. Petter Björquist is a PhD in Biology/Biochemistry from Gothenburg University, 50 + publications in peer reviewed journals, several book chapters and patents. Q. What is the most trending areas of cellular therapies currently? A. I would say that is 1) CAR T-cell Therapy. This field has exploded, and started a new era in cancer treatment. 2) Genome…